N1-Me-pseudo-UTP is a suitable reagent for the production of mRNA for treatment and vaccine research. To improve the performance of modified mRNA, partially or totally replace UTP with this modified UTP.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
